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Limb budsMembers of the T-box family of transcription factors play essential roles in cell type speciﬁcation,
differentiation, and proliferation during embryonic development. All T-box family members share a common
DNA binding domain – the T-domain – and can therefore recognize similar sequences. Consequently, T-box
proteins that are co-expressed during development have the potential to compete for binding at downstream
targets. In the mouse, Tbx6 is expressed in the primitive streak and presomitic mesoderm, and is sharply
down-regulated upon segmentation of the paraxial mesoderm. We sought to determine the phenotypic and
molecular consequences of ectopically expressing Tbx6 within the segmented paraxial mesoderm and its
derivatives using a 3-component transgenic system. The vertebral column, ribs, and appendicular skeleton
were all affected in these embryos, which resembled Tbx18 and Tbx15 null embryos. We hypothesize that
these phenotypes result from competition between the ectopically expressed Tbx6 and the endogenously
expressed Tbx18 and Tbx15 at the binding sites of target genes. In vitro luciferase transcriptional assays
provide further support for this hypothesis.artment of Biological Sciences,
burgh, PA 15260, USA. Fax: +1
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
One hallmark of the vertebrate embryo is segmentation of the
paraxialmesoderm (PAM) into reiterative somites ﬂanking the central
neural tube. PAM arising from the primitive streak (PS) forms two
strips of mesenchymal tissue lateral to the axial mesoderm thus
establishing the presomitic mesoderm (PSM) (Tam and Beddington,
1987). Somites arise through segmentation of the anterior region of
the PSM via a mesenchymal-to-epithelial transition. Somites later
undergo differentiation to form the sclerotome, dermatome, and
myotome, which will become the ribs and vertebrae, dermis, and
skeletal muscle of the adult animal, respectively (Christ et al., 2000).
The sclerotome region of each somite is further divided into a rostral
(R) and caudal (C) half, each with different molecular and physical
characteristics. Proper R–C speciﬁcation is essential for the process of
re-segmentation, which joins the caudal sclerotome portion of one
somite to the rostral portion of the next more posterior somite. Re-
segmentation ultimately results in the formation of a vertebral unit
(Huang et al., 1996).
The activity of tissue-speciﬁc transcription factors drives the
establishment of speciﬁc cell types. Genetic and molecular data
demonstrate the important roles that the T-box family of transcriptionfactors play in cell type speciﬁcation, differentiation and proliferation
during embryonic development (Naiche et al., 2005). Mutations in
human TBX1, TBX3, TBX4, TBX5, and TBX22 result in the human
syndromes DiGeorge, ulna-mammary, Small Patella, Holt–Oram, and
X-linked cleft palate with ankyloglossia, respectively (Baldini, 2003;
Bamshad et al., 1997; Basson et al., 1997; Bongers et al., 2004;
Braybrook et al., 2001). A conserved DNA binding domain known as
the T-domain deﬁnes the T-box family. Outside of this domain, family
members share very little similarity. Conservation of the T-box DNA
binding domain allows for all T-box transcription factors thus far
examined to bind a core 5′-AGGTGT-3′ (Naiche et al., 2005). T-box
transcription factors can serve as transcriptional activators or
repressors, with some factors serving as both depending on their
interacting partners (Kawamura et al., 2008). Functional speciﬁcity is
in part determined by preferences for orientation of the half-sites and
for bases ﬂanking the conserved core, and physical interactions with
different co-factors (Conlon et al., 2001). Additionally, when T-box
proteins are endogenously co-expressed there appears to be compe-
tition for binding sites within the enhancers of common target genes.
For example, during mouse heart development, Tbx2, a transcrip-
tional repressor, competes with Tbx5, an activator, for binding at the
ANF enhancer (Habets et al., 2002). Competition has also been
observed between ectopically and endogenously expressed T-box
transcription factors during zebraﬁsh mesoderm formation (Goering
et al., 2003; Habets et al., 2002).
Mouse Tbx6 is expressed in the PS and PSM beginning at
embryonic day (e) 7.5, and is critical for the proper speciﬁcation
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and Papaioannou, 1998; White et al., 2003). Tbx6 mRNA and protein
are rapidly down-regulated as the PSM segments to form the somite.
Tbx6−/− embryos form only 7–9 abnormal anterior somites;
posterior to the forelimb bud ectopic neural tubes form in place of
the somites. Genetic and transcriptional studies show that Tbx6
cooperates with other signaling pathways, including Notch and Wnt
signaling, to activate transcription of known downstream targets —
Ripply2, Mesp2, Dll1, and Msgn1 (Hitachi et al., 2008; Hofmann et al.,
2004; Wittler et al., 2007; Yasuhiko et al., 2006). We sought to
determine the phenotypic and molecular consequences of ectopic
Tbx6 expressionwithin the segmented PAM and its derivatives, where
it is normally not expressed. Using a 3-component transgenic system
we drove ectopic Tbx6 expression in the formed somites and limb
buds and show that forced Tbx6 expression within the segmented
PAM results in phenotypes that resemble that of Tbx18 null embryos,
while expression of Tbx6 in the lateral plate mesoderm (LPM) results
in Tbx15 null-like phenotypes. We propose that these phenotypes
arise due to competition between the ectopically expressed Tbx6
with endogenously expressed Tbx18 and Tbx15 at the binding sites of
target genes.Materials and methods
Generation of TRE:myc-Tbx6 transgenic mice
The TRE:myc-Tbx6 construct was generated by cloning a 5× Myc
tag in-framewith the full-length Tbx6 cDNA into the pTRE2-hyg vector
(Clontech). The insert was released from the vector and gel puriﬁed.
Transgenicmicewere generated by pronuclear injection into fertilized
FVB/N eggs (Transgenic Core Facility, University of PittsburghMedical
Center). Three founder lines were generated. Mice were genotyped
for the presence of the transgene by PCR using primers speciﬁc to
the TRE and Tbx6 (forward 5′-GCCATCCACGCTGTTTTGAC-3′; reverse
5′-CCAGAGAGGAAGCAATCCAGTTTAG-3′), which generates a 453 bp
product.Mice
The Dll1-msd:Cre Tg33 line has previously been described (Wehn
et al., 2009). R26-rtTA B6.Cg-Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/J mice
were obtained from Jackson Laboratories (Belteki et al., 2005).
Animals were mated and checked daily for the presence of a
copulation plug. Noon on the day of the plug was considered e0.5.
Doxycycline (DOX, 1.6 mg/ml) plus sucrose (50 mg/ml) was added to
the drinking water of pregnant females at the designated times.
Females were sacriﬁced and embryos dissected from e9.5 to e13.5.
Control embryos were hemizygous for both the R26-rtTA and Dll1-
msd:Cre transgenes. All animal work was performed in accordance
with the guidelines established by the University of Pittsburgh's
Institutional Animal Care and Use Committee.Fibroblasts
Fibroblasts were derived from 3-component embryos according to
standard protocols (Abbondanzo et al., 1993). Brieﬂy, e13.5 embryos
were dissected free of extraembryonic tissue and the head and liver
were removed. Isolated tissue wasmacerated by passing it through an
18-gauge needle and then cultured in DMEM supplemented with 10%
fetal calf serum. Fibroblasts were expanded and at the fourth passage
plated onto coverslips for immunoﬂuorescence or Western blotting.
DOX was added to the tissue culture media at a ﬁnal concentration of
1 μg/mL for 36 h before processing.Immunoﬂuorescence
Fibroblasts on coverslips were ﬁxed in 4% paraformaldehyde,
permeabilized in 0.1% Triton X-100 in PBS, and blocked in 5% goat
serum in PBS. Coverslips were incubated with mouse anti-myc (9E10,
Sigma, 1:250 dilution in blocking buffer) and rabbit anti-GFP antibody
(Torrey Pines Biolabs, 1:1000 dilution in blocking buffer), washed and
then incubated with goat anti-mouse 568 and goat anti-rabbit 488-
secondary antibody (Molecular Probes, 1:500 dilution in blocking
buffer) and TO-PRO 3 nuclear stain (Molecular Probes, 1:1000 dilution
in blocking buffer). Cells were mounted on slides using Vectashield
mounting medium and optical sections were visualized on a BioRad
scanning laser confocal microscope. Photoshop was used to merge the
different channel images. The number of EGFP or myc-Tbx6 positive
nuclei in each frame was divided by the total number of nuclei to
determine the percentage of EGFP- and Tbx6-positive cells. Two images
derived from two separate coverslips were counted to obtain the
average percentage of ﬁbroblasts that were EGFP- and Tbx6-positive.
Whole-mount in situ hybridization
Whole-mount in situ hybridization was performed as previously
described (Wilkinson, 1992) using antisense riboprobes for Dll1, Fgf8,
mesp2, myogenin, Ripply2, Tbx6, Tbx18, Tbx15 and uncx4.1. Hybridiza-
tions and washes were performed at 63 °C.
Immunocytochemistry
Immunocytochemistry was performed as described in Nagy et al.
(2003). The Tbx6 N-terminal afﬁnity puriﬁed antibody was used at a
1:500 dilution (White and Chapman, 2005). Goat anti-rabbit:HRP-
conjugated secondary antibody (Jackson ImmunoResearch) was used
at a 1:500 dilution and stainingwas performed in the presence of DAB,
hydrogen peroxide and nickel chloride.
Western blotting
HEK293T cells transfected with the indicated expression plasmids
or tissue dissected from approximately ten e10.5 embryos were
homogenized in RIPA buffer. Bradford dye assays were performed to
determine total protein concentration, and equal amounts of protein
were loaded onto 7.5% SDS-PAGE gels, transferred to nitrocellulose,
and blotted with 1:500 anti-9E10 (anti-myc, Sigma) or 1:500 anti-N-
terminal Tbx6 antibody (White and Chapman, 2005) in blocking
buffer (TBTT containing 5% NFDM), and subsequently incubated in
goat anti-rabbit:HRP-conjugated secondary antibody (Jackson Immu-
noResearch; 1:2500 dilution in blocking buffer). Blots were stripped
and re-probed with 1:500 anti-tubulin (Sigma) or 1:500 anti-actin
(Cytoskeleton) in blocking buffer as a loading control.
Skeletal preparations
Skeletons from e13.5 embryos were stained with alcian blue as
described by Nagy et al. (2003), except that the staining was
performed at 37 °C. Stained embryoswere cleared in benzyl benzoate:
benzyl alcohol.
Plasmid constructs
Full-length Tbx6, Tbx18, and Tbx15 cDNAswere cloned in-framewith
the N-terminal myc tag of the mammalian expression vector pCS3mT.
PCRampliﬁed Tbx15-DBDandTbx18-DBDwere cloned in framewithan
N-terminal myc tag and a nuclear localization signal (NLS) of
pCS2mTNLS. The luciferase reporter plasmid contained a 200 basepair
region of the Dll1-msd enhancer element cloned upstream of the β-
globin minimal promoter in pGL4 vector (Promega), where one
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β−globin:Dll1-msd-luciferase). PCR primers used to amplify the Dll1-
msd enhancer region from genomic DNA were: Dll1fwd: 5′-
CCTCTTTACTCCACC-3′, Dll1rev: 5′-CCTAAATGATCAAGC-3′. PCRprimers
used to amplify the DNA binding domains of Tbx15 and Tbx18 were:
Tbx15-DBD fwd: 5′-CGAGATTCAGGTGGACTTC-3′, Tbx15-DBD rev: 5′-
TGTTTCTGCCAGAATCTCTG-3′, Tbx18-DBD fwd: 5′-CCCGAGAGTA-
GATCTGCAAG-3′, Tbx18-DBD rev: 5′-CTGTTCCTCCCAGAGTC-3′.
Luciferase assays
1×105 HEK293T cells were plated per well in a tissue culture-
treated 96-well dish, and transfected with Lipofectamine 2000
(Invitrogen) in suspension. 10 ng of pGL4M-β−globin:Dll1-msd-
luciferase was transfected per well along with 1 ng of pRenilla
Luciferase-CMV, which served as an internal control. The amount of
Tbx6, Tbx18, and Tbx15were as indicated, and empty pCS3 vector was
transfected when necessary to keep amounts of transfected DNA
constant. Twenty-four hours after transfection, cells were processed
with Dual Glo luciferase reagent (Promega) according to the
manufacturer's directions, and the intensity measured on a Berthold
XS3 LB960 luminometer. Luciferase readings were normalized to the
Renilla luciferase, and ratios were normalized to pGL4-β−globin:Dll1-
msd transfected with an empty pCS3 vector control. Statistical
analyses were performed using one-way ANOVA tests.
Preparation of nuclear lysates
Nuclear lysates were prepared according to a protocol adapted
from Wadman et al. (1997). Brieﬂy, 5×107 HEK293T cells were
washed twice with ice cold PBS and lysed with 250 μL of Buffer A
(10 mM HEPES, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT, with added
protease inhibitors, pH 7.9) and incubated on ice for 15 min. NP-40
was added to a ﬁnal concentration of 0.5%, cells were vortexed for
10 s, and nuclei were isolated by centrifugation at 6500 g for 30 s. The
nuclear pellet was resuspended in 150 μL Buffer C (20 mM HEPES,
1.5 mM MgCl2, 420 mM NaCl, 0.2 mM EDTA, 25% v/v glycerol, with
protease inhibitors, pH 7.9) and rotated at 4 °C for 30 min. Lysed
nuclei were centrifuged at full-speed for 10 min, and the supernatant
was collected as the “nuclear fraction”. A Bradford assay was
performed to determine total protein concentration, and equivalent
amounts of total protein were used in electrophoretic mobility shift
assay (EMSA) reactions.
EMSA
Oligonucleotides were end-labeled with γ-32P-ATP using T4
polynucleotide kinase, annealed and double-stranded probes puriﬁed
using Micro Bio-Spin P-30 Tris puriﬁcation columns (BioRad). The
percentage of double- versus single-stranded probe was determined
by analyzing probes on an 18% non-denaturing PAGE, and quantita-
tion using the Fuji BAS-2500 Phosphoimager and ImageGauge
software. The percentage of double-stranded probe recovered was
greater than 85% in all cases. Subsequently, the amount of double-
stranded probe for each experiment was standardized so that
equivalent amounts were used. All EMSA binding reactions were
prepared in a ﬁnal reaction volume of 15 μL in BBT buffer (25 mM
HEPES pH 7.4, 75 mM NaCl, 1 mM DTT. 0.25 mM EDTA, 0.1% NP-40,
1 mMMgCl2, 10% glycerol, 10 μg/mL BSA). 0.1 mg/mL poly dI–dC was
added as a non-speciﬁc competitor. Binding reactions were incubated
at room temperature for 45 min. 1 μg of anti-myc antibody (9E10,
Sigma) was added and reactions were incubated at room temperature
for 15 min prior to being resolved on a 4% non-denaturing PAGE
(37.5:1). Gels were exposed to a phosphoimager screen and imaged
on a Fuji BAS-2500 Phosphoimager. Oligonucleotides used
(bold letters indicate core binding sequence): Dll1BS1: 5′-TCACTG-TAGGTGTTGCTGTCCTGT-3′; Dll1BS2: 5′-TCCCGAGGTGTGATTCTTGGA-
3′; Dll1BS3: 5′-GTGGATCCAGGTGTCCTCACTGGGCTGC-3′; Dll1BS4: 5′-
TGGATCCTAGGGTGTACCTGACGGCTGC-3′.
Results
Transgenic system to inducibly express Tbx6
We have utilized a 3-component transgenic system to misexpress
full-length myc-tagged Tbx6 in a variety of mesoderm derivatives
during development. This system, based on that described by Belteki
et al. (2005) and Yu et al. (2005), consists of three separate transgenes
(schematic shown in Supplemental Fig. 1). The ﬁrst is Cre recombinase
under the control of the Dll1:msd enhancer, which expresses Cre
recombinase within the PSM and all downstream derivatives, in
addition to othermesoderm derivatives including the lateral plate and
intermediate mesoderm (Wehn et al., 2009). The second transgenic
line consists of reverse tetracycline-transactivator (rtTA)-IRES-EGFP
inserted at the ROSA26 locus downstream of a ﬂoxed stop of
transcription cassette; rtTA is only active when it associates with
doxycycline (DOX). The third transgenic line consists of a full-length
myc-tagged mouse Tbx6 under the control of the tetracycline-
responsive element (TRE:myc-Tbx6); the rtTA bound to DOX activates
transcription from the TRE. We generated three independent TRE:
myc-Tbx6 transgenic lines all of which inducibly express Tbx6 at
similar levels (data not shown).
To verify that the TRE:myc-Tbx6 transgene expressed protein of the
appropriate size we generated ﬁbroblasts from embryos carrying all
three transgenes. In the presence of DOX, but not in its absence, a
nuclear localized, myc-Tbx6 protein of the appropriate molecular
weight was produced (Supplemental Fig. 1).
To generate embryos containing all three transgenes, we mated
TRE:myc-Tbx6/+; rtTA/rtTA mice to mice homozygous for the Dll1-
msd:Cre transgene. Pregnant mice were administered DOX in their
drinking water beginning at e6.5 or e8.5 and embryos were dissected
at e10.5 or e13.5, respectively. At e10.5, whole-mount in situ
hybridization (WISH) revealed the expression domains of both
endogenous and ectopic Tbx6 mRNA. Endogenous Tbx6 is limited to
the PS and PSM, located in the tip of the tail (Fig. 1a). In addition to
this expression domain, 3-component embryos had mosaic Tbx6
expression in the PAM and limb buds (Fig. 1a′–a″). Interestingly,
somites in 3-component embryos appeared morphologically normal.
Whole-mount antibody staining for Tbx6 at e10.5 revealed a gap
between the tailbud and the ectopic expression domain (Fig. 1b′–b″).
Robust expression was not observed until somite 4 (S4), with S1
considered the most recently formed somite. To determine relative
levels of endogenous and ectopic Tbx6 protein in these embryos, we
dissected tailbuds, somites 1–3, somites 4–5, and limb buds from
e10.5 embryos and used these for Western blot analysis. The myc-
Tbx6 protein is a larger protein and thus endogenous and ectopic Tbx6
protein can be distinguished by Western blotting using a Tbx6
antibody (Fig. 1d). Endogenous Tbx6 protein was detected in isolated
tailbuds, however myc-Tbx6 was absent. Low but detectable levels of
myc-Tbx6 were found in somites 1–3, which corresponds to the gap
observed in the whole-mount antibody staining. Somites 4–5
expressed increased levels of myc-Tbx6, and the limb buds showed
robust expression.
Axial and appendicular skeletal defects in Tbx6 misexpression embryos
To examine the consequences of ectopically expressing myc-Tbx6
expression in the formed somites and limbs, pregnant females were
treated with DOX at e8.5 and e13.5 embryos were examined for both
gross and skeletal morphology. Despite the apparent normal
segmentation of the PAM at earlier stages, 3-component embryos
exhibited striking skeletal defects at e13.5. Although the phenotypes
Fig. 1.Mosaic expression of myc-Tbx6 in 3-component embryos. WISH of Tbx6 expression in a control (a) and 3-component (a′–a″) e10.5 embryos. Tbx6 expression in the control
embryo is restricted to the tailbud and PSM (staining in the head is trapped color reactants). (a′–a″) Two different 3-component embryos with Tbx6 transcripts in the tailbud and
mosaic Tbx6 expression throughout the somitic mesoderm and limb buds. Whole-mount antibody staining using a Tbx6 antibody in control (b) and 3-component (b′–b″) e10.5
embryos. Anti-Tbx6 staining revealed Tbx6 protein localization in the tailbud (b) in the control embryo. In addition to tailbud expression, ectopic Tbx6 staining is found throughout
the somitic mesoderm and limb buds and similar to the mRNA expression, the protein is mosaically expressed (b′–b″). (b″) A gap in Tbx6 endogenous and ectopic expression can be
seen between the tailbud and somite 4. Somites 1–3 lie between the red arrows. (c) Tail region from an e10.5 embryo showing the planes of dissection of tissues used for Western
blot analysis shown in panel d: tailbud (TB), somites 1–3 (s1–3), somites 4–5 (s4–5) and the fore limb bud (ﬂb). (d) Westerns blotted with either anti-Tbx6 (α-Tbx6), anti-myc (α-
Myc), orα-Tubulin (α-Tub) antibodies. Tubulin served as a loading control. Endogenous Tbx6, which is a smaller molecular weight (red asterisk), was only detected in tailbud tissue,
while ectopic myc-Tbx6 was found at low levels in s1–3, higher levels in s4–5, and was robust within the limb buds. Ectopic Myc-Tbx6 was not detected in the tailbud tissue.
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vertebral column and appendicular skeleton. Of the thirty-four 3-
component embryos examined, 100% had vertebral abnormalities
including fusion and/or malformation of the atlas and axis, the most
anterior somitic derivatives, and fusions of the vertebral pedicles in
the anterior of the embryo (Fig. 2c–c′). The most severely affected
embryos displayed fusions along the entire body axis (85%).
Additionally, the distal portions of the ribs were often missing or
underdeveloped (91%). Beyond e13.5, 3-component embryos became
edemic and died shortly thereafter in utero precluding analysis at later
developmental stages. To increase the level and presumably the
number of cells that express myc-Tbx6, we generated embryos that
were hemizygous for the Dll1-msd:Cre and rtTA transgenes, but
homozyogous for the TRE:myc-Tbx6 transgene. These homozygous
embryos had more severe phenotypes than the hemizygotes;
speciﬁcally, pedicle morphology was affected along the entire axis
and vertebral bodies were also malformed (Fig. 2d–d′).
At e13.5, 3-component embryos were noticeably smaller and had
underdeveloped limbs (Fig. 2a). At the gross morphological level, the
limb buds of control littermates displayed distinguishable digits
within the limb bud, in contrast to the paddle-shaped limbs without
distinguishable digit condensations of 3-component embryos. Skele-
tal analysis of these limbs revealed shortened and malformed
humerus, radius and ulna (100%), as well as femur, tibia and ﬁbula
(97%), and occasionally the distal limb elements were missing
altogether (Fig. 2f). 3-component embryos also had hypoplastic
scapulae (91%), which contained an ectopic foramenwithin the center
of the blade in 21% of the embryos.
Ectopic expression of Tbx6 in the limb buds and somites resemble Tbx15
and Tbx18 null embryos
Ectopic expression of myc-Tbx6 within the limbs and somitic
tissue results in severe skeletal phenotypes. One explanation for thesephenotypes is that misexpression of Tbx6 drives expression of its own
downstream targets and it is the ectopic expression of these targets
that causes the observed phenotypes. We therefore examined the
expression of the four conﬁrmed downstream targets of Tbx6: Dll1,
Mesp2, Msgn1, and Ripply2 (Hitachi et al., 2008; White and Chapman,
2005; Wittler et al., 2007; Yasuhiko et al., 2006). Expression of these
targets at e10.5 was found only in their endogenous expression
domains (Fig. 3 and data not shown), suggesting that these
phenotypes were not due to misexpression of Tbx6 target genes. It
is important to note that even in the limb buds where the level of
myc-Tbx6was highest, there was no ectopic expression of Tbx6 target
genes.
To further investigate the cause of the observed phenotypes, we
examined other T-box transcription factors that are expressed within
the somites and limb buds, hypothesizing that ectopic Tbx6 could
either directly alter the expression of these T-box factors or compete
for binding at their downstream targets, as has been observed for
other T-box transcription factors (Goering et al., 2003; Habets et al.,
2002). The phenotypes observed in 3-component embryos closely
resemble Tbx15 and Tbx18 null embryos, as well as embryos in which
Tbx5 function is removed after initiation of the limb bud. Tbx15 null
embryos show abnormalities within the atlas and axis (Singh et al.,
2005). Tbx18 null embryos also display phenotypes that overlap with
our 3-component embryos, speciﬁcally caudalization of the somites,
which leads to expanded and fused pedicles of the vertebrae (Bussen
et al., 2004). Late removal of Tbx5 results in a scapular foramen, and
shortening and malformations of the forelimbs (Hasson et al., 2007).
Tbx5 and Tbx4 initiate and maintain outgrowth of the fore- and
hindlimb, respectively, via a feedback loop where direct activation of
Fgf10 expression within the lateral plate mesoderm maintains Fgf8
expression in the overlying apical ectodermal ridge (AER) (Agarwal et
al., 2003). Loss of Tbx5 results in the loss of Fgf10 and consequently
loss of Fgf8 expression in the AER thus halting of limb outgrowth
(Naiche and Papaioannou, 2003; Rallis et al., 2003; Takeuchi et al.,
Fig. 2. Three-component embryos display vertebral and limb defects. Grossmorphology and skeletal preparations of control and 3-component (Tg) embryos dissected at e13.5. (a) 3-
component embryos were smaller than normal littermates, and had paddle-shaped limb buds, whereas control littermates had begun to form distinct digits. Alcian blue-stained
skeletons of control (b, e) and 3-component embryos (c, d, f). Panels c and f show an embryos hemizygous for TRE:myc-Tbx6, while the embryo in panel d is homozygous for the TRE:
myc-Tbx6 transgene. Primed panels show a higher magniﬁcation of the embryos in panels b–d. The atlas (at) and axis (ax) are clearly distinct structures in the control embryo (b, b′).
(c and d) 3-component embryos displayed fusions and malformations of the atlas and axis (at/ax?, c′) and expansion and fusions of the vertebral pedicles (red arrow and
asterisk, c′). Vertebral body morphology was also affected in 3-component embryos, with more severe phenotypes observed in the embryo homozygous for the TRE:myc-Tbx6
transgene (d′). Forelimb skeletal preparations revealed shortened and malformed forelimb bones in the 3-component (f) embryo compared to the littermate control (e). An
ectopic foramen in the scapula (arrow) was evident in 21% of 3-component embryos (f). Abbreviations used: forelimb, ﬂ; hindlimb, hl; pedicle, pd.
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embryos to indirectly assess Tbx5 function. Fgf8 was expressed in
the AER of both control and 3-component embryos (Fig. 4a),
suggesting that misexpression of Tbx6 does not inhibit this function
of Tbx5.
While Tbx18 null embryos do not display limb defects, Tbx15 null
embryos display a delay in endochondral bone formation in the limbs
with alterations in bone shape and size. Tbx15 null embryos also
exhibit hypoplastic scapulaewith ectopic foramen (Singh et al., 2005),
similar to phenotypes observed in the 3-component embryos.
Altogether this suggests that Tbx15 may be a primary T-box
transcription factor affected by ectopic expression of Tbx6 in the
limbs. Misexpression of myc-Tbx6 in the PAM and limb buds
phenocopies aspects of the Tbx18 and Tbx15 null embryos. It is
conceivable that in these embryos ectopic Tbx6 results in the down-
regulation of Tbx15 and Tbx18 expression and this down-regulation
results in the observed phenotypes. To test this, we examined Tbx15
and Tbx18 expression in 3-component embryos at e10.5, focusing onFig. 3. Tbx6 downstream target gene expression in control and 3-component embryos is in
indistinguishable from control littermates at e10.5. (a) Dll1 is expressed in the tailbud, PSM
expressed at the anterior somitic boundary. Neither Dll1 nor mesp2 are expressed in the lim
fore- and hindlimb buds.changes in limb and somitic expression domains that might be altered
due to ectopic Tbx6 expression. At this stage, Tbx15 is normally
expressed within the limb buds, while Tbx18 is expressed in the
rostral portion of each somite, in addition to the limb buds (Agulnik
et al., 1998; Kraus et al., 2001; Singh et al., 2005). Expression of Tbx15
and Tbx18 appeared unaffected in our 3-component embryos (Figs. 4b
and c), suggesting that ectopic Tbx6 is not causing these phenotypes
by down-regulating Tbx15 or Tbx18 expression.
The vertebral defects in Tbx18 null embryos are thought to arise
from a failure to maintain rostral somite identity, with the hypothesis
that the more caudal cells eventually invade the rostral region
(Bussen et al., 2004). Expression of uncx4.1, which is normally
restricted to the caudal portion of each somite, expands slightly into
the rostral portion of the Tbx18 null somites. This expansion occurs
only in the more anterior and thus more mature somites, suggesting
that Tbx18 is not required for the initial repression of uncx4.1
expression, but is instead required to maintain rostral–caudal
patterning. In Tbx6 3-component embryos uncx4.1 expression wasdistinguishable. The expression of Tbx6 target genes in 3-component embryos (Tg) is
, caudal portion of each somite, and in neural tissue. mesp2 (b) and Ripply2 (c) are both
b buds where the highest levels of ectopic myc-Tbx6 are found. Red asterisks mark the
Fig. 4. Spatial expression of limb and somitic marker genes is maintained in 3-component embryos. (a) Fgf8 expression in the AER of control and 3-component (Tg) embryonic limb
buds are indistinguishable. (b) Tbx15 is expressedwithin the fore- and hindlimb buds of control embryos. (c) Tbx18 is expressedwithin the limb buds and the anterior of each somite.
There are no observable differences in Tbx15 or Tbx18 expression levels or pattern between control and 3-component embryos in the limb buds or somites. (d) uncx4.1 is expressed
within the caudal half of each somite in both control and 3-component embryos, however expression levels are higher in 3-component embryos. (e) myogenin expression in the
myotome compartment of the somites was similar in both control and in 3-component embryos. Abbreviations used: ﬂ, forelimb bud; hl, hindlimb bud; h, heart.
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rostral–caudal somite identity is initially established in these
embryos. Interestingly, uncx4.1 staining appeared darker suggesting
that it was expressed higher in the 3-component embryos compared
to control littermates (Fig. 4d). Somitic defects in the Tbx18 nulls are
limited to the sclerotome compartment as expression of myogenin
within the myotome was unaltered (Bussen et al., 2004). Similarly,
myogenin expression in the 3-component embryos was unaltered
(Fig. 4e).
Luciferase assays demonstrate competition between T-box factors
Both Tbx15 and Tbx18 encode transcriptional repressors (Farin et al.,
2007). We hypothesize that ectopic Tbx6 in 3-component embryos
interferes with Tbx15 and Tbx18 function at the level of binding to the
enhancer of downstream targets. To testwhether this can occur,weﬁrst
cloned full-length Tbx15 and Tbx18 into the pCS3mT expression vector
to produce myc-tagged fusion proteins. Constructs were transfected
into 293T cells and protein size and expression levels were veriﬁed by
Western blotting. While the myc-Tbx15 and myc-Tbx18 proteins were
of the predicted molecular weights, myc-Tbx18 was produced at
approximately two-fold greater than myc-Tbx6, and myc-Tbx15 was
produced at 1.7-fold less than myc-Tbx6 when equivalent amounts of
expression plasmids were transfected (Fig. 5a).
Dll1 is a bona ﬁde target of Tbx6 and is also thought to be a target of
Tbx18 in the somites (Bussen et al., 2004; Hofmann et al., 2004;White
and Chapman, 2005). In the segmented PAM, Dll1 expression is
conﬁned to the posterior of each somite via repression by Tbx18 in the
anterior compartment (Bussen et al., 2004). We performed transcrip-
tional assays using a 200 bp region of the Dll1 enhancer (Dll1-msd)
that contains two consensus and two non-consensus T-box binding
sites to drive luciferase expression. Luciferase assays revealed that on
its own myc-Tbx6 activates transcription from the Dll1-msd enhancer
(Fig. 5c). The relative luciferase units (RLUs) for myc-Tbx18 and myc-
Tbx15 alone were less than background, suggesting that in this assaysystem they functioned as repressors (Figs. 5c and d). To test whether
Tbx15 and Tbx18 could compete with Tbx6 at the Dll1-msd enhancer,
increasing amounts of myc-Tbx18 or myc-Tbx15 expression con-
structs were added to a constant amount of myc-Tbx6. This resulted in
a decrease in luciferase activity (Figs. 5c and d).
We further conﬁrmed these results using a second known target of
Tbx18, atrial natriuretic factor (ANF), which is expressed during
cardiac morphogenesis. The ANF enhancer contains two consensus T-
box binding sites in inverted orientation relative to each other (Brown
et al., 2005). Although ANF is not an endogenous target of Tbx6, myc-
Tbx6 weakly activated transcription from this enhancer (Fig. 5e).
Neither Tbx18 nor Tbx15 had signiﬁcant activity at the ANF enhancer
(Fig. 5e and Supplemental Fig. 2a). Addition of increasing amounts of
myc-Tbx18 lowered the transcriptional activity of myc-Tbx6 from this
promoter as well (Fig. 5e). Curiously, adding increasing amounts of
myc-Tbx15 did not cause a linear decrease in RLUs, and only repressed
myc-Tbx6 mediated transcription a maximum of 2-fold (Supplemental
Fig. 2a). Altogether, these results suggest that a competition between
T-box factors can occur for binding sites found in the enhancers of
target genes, however the robustness of competition is likely to be T-
box factor dependent.
To examine whether this competition occurred at the level of DNA
binding, we used the DNA binding domains of Tbx15 and Tbx18 fused
to an N-terminal myc-tag and nuclear localization sequence (NLS)
in our luciferase assays. Interestingly, the DNA binding domain
alone of Tbx15 and Tbx18 were sufﬁcient to compete with Tbx6 at the
Dll1-msd enhancer, further supporting that the apparent competition
between Tbx6 and Tbx15/Tbx18 occurs at the level of DNA binding
(Fig. 5f and Supplemental Fig. 2b). Finally, we examined the ability of
Tbx15 and Tbx18 to bind to the putative T-box binding sites (BS)
found in the Dll-msd enhancer. We have previously shown that Tbx6
can bind to BS1 and BS2, but not BS3 or BS4 (White and Chapman,
2005). Like myc-Tbx6, myc-Tbx18 also bound to BS1 and BS2, while
myc-Tbx15 only bound to BS1 by EMSAs (Supplemental Fig. 3).
Neither bound to BS3 or BS4.
Fig. 5. Transcriptional assays reveal competition between Tbx15/Tbx18 and Tbx6 at multiple enhancers. (a) Lysates from HEK293T cells transfected with equal amounts of myc-
Tbx6, -Tbx15 or -Tbx18 expression vectors wereWestern blotted with an anti-myc antibody. Twice as much myc-Tbx18 was produced as compared to myc-Tbx6, while 1.7-fold less
myc-Tbx15 was produced as compared to myc-Tbx6. (b) Western blotting of lysates from HEK293T cells transfected with equal amounts of myc-Tbx6, myc-Tbx15-DNA binding
domain (myc-T15-DBD) or myc-Tbx18-DNA binding domain (myc-T18-DBD). Western blots were stripped and re-probed with α-tubulin to verify loading (a, b). myc-T15-DBD and
myc-T18-DBD were produced at approximately the same level, while myc-Tbx6 was produced at approximately 37% more than either myc-T15-DBD or myc-T18-DBD. (c–d) myc-
Tbx18 and myc-Tbx15 slightly repressed transcription from the Dll1-msd enhancer, while myc-Tbx6 activated transcription. Addition of increasing amounts of myc-Tbx18 or myc-
Tbx15 to a constant amount of myc-Tbx6 lowered overall RLUs. (e) myc-Tbx6 activated low levels of transcription from the ANF enhancer, while myc-Tbx18 had little activity at this
enhancer. Addition of increasing amounts of myc-Tbx18 to a constant amount of myc-Tbx6 lowered the overall RLUs from the ANF enhancer. (f) The myc-Tbx18-DBD had no
signiﬁcant effect on luciferase expression from the Dll1-msd enhancer. Addition of increasing amounts of myc-Tbx18-DBD to a constant amount of myc-Tbx6 led to a linear decrease
in luciferase activity. Statistical analysis was performed using one-way ANOVA tests to determine the effect of adding increasing amounts of Tbx18 or Tbx15 expression plasmids on
the transcriptional activity of a constant amount of Tbx6 at the speciﬁed enhancers. Signiﬁcant effects were observed at the Dll1-msd enhancer for the addition of myc-Tbx18
[F(4, 25)=68.46, pb0.0001], myc-Tbx15 [F(4, 25)=5.689, p=0.0021], and myc-Tbx18 DBD [F(4, 25)=6.788, p=0.0008], as well as at the ANF enhancer for the addition of
myc-Tbx18 [F(4, 25)=13.53, pb0.0001].
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We investigated the phenotypic consequences of ectopically
expressing a full-length, myc-tagged Tbx6 in the segmented PAM and
LPM. This resulted in axial skeletal phenotypes including fusion and/or
malformations of the atlas and axis, fusionsof thevertebral pedicles, and
underdeveloped distal portions of the ribs. Limb phenotypes included
delayed digit formation, shortened and malformed fore- and hindlimb
bones. Underdevelopment of the ribs and digits may reﬂect a
developmental delay of 3-component embryos as they were noticeably
smaller than the control littermates at e13.5. Additionally, these
embryos displayed hypoplastic scapulae, which contained an ectopic
foramen within the center of the blade 21% of the time. The scapula is
derived from both lateral plate and somitic tissue (Huang et al., 2000),
both of which expressed myc-Tbx6 in our 3-component embryos. The
observed phenotypes were highly variable most likely due to the high
degree of mosaic myc-Tbx6 expression observed by both WISH and
whole-mount antibody staining. By e13.5, embryos became edemic,
precluding analysis at later developmental stages. The cause of theedema and embryonic death has yet to be investigated, although it is
interesting to note that the Dll1-msd:Cre drives expression within the
vasculature, which may contribute to the edema (Wehn et al., 2009).
To understand the mechanisms underlying the observed pheno-
types, we ﬁrst examined the expression of the Tbx6 target genes Dll1,
Mesp2, Ripply2 and Msgn1. As none of these were misexpressed in 3-
component embryos, we concluded that the phenotypes did not result
from up-regulation of Tbx6 targets. It is not surprising that Tbx6 target
genes were not ectopically expressed in these embryos since their
expression is not solely dependent on Tbx6. In addition to Tbx6,
Mesp2 expression is also dependent on Notch and FGF signaling
(Oginuma et al., 2008; Yasuhiko et al., 2006). Expression of both Dll1
and Msgn1 requires cooperation between Tbx6 and LEF/TCF tran-
scription factors (Hofmann et al., 2004; Wittler et al., 2007).
Regulation of Ripply2 expression requires both Tbx6 and Mesp2
(Dunty et al., 2008; Hitachi et al., 2008). This complex regulatory
network ensures that target genes are expressed in the correct time
and place during development, effectively prohibiting ectopic
expression in the absence of the other necessary factors.
411A.K. Wehn, D.L. Chapman / Developmental Biology 347 (2010) 404–413Since ectopic expression of Tbx6 did not induce ectopic expression
of its own downstream targets, the question of how these phenotypes
arose remained. Four T-box transcription factors (Tbx2, Tbx15, Tbx18,
and Tbx22, all transcriptional repressors) are expressed in the somites.
Tbx2 function is required for formation of the intersomitic blood
vessels (Harrelson and Papaioannou, 2006), and therefore does not
contribute to the patterning of the vertebral column or ribs. Similarly,
Tbx22 null embryos do not exhibit vertebral or rib defects, but rather
display a cleft-palate phenotype (Bush et al., 2002). Strikingly, the
observed phenotypes of 3-component embryos resembled those of
Tbx15 and Tbx18 null embryos. We showed that Tbx15 and Tbx18
expression domains were not altered in our 3-component embryos,
indicating that ectopic myc-Tbx6 did not down-regulate their
expression to generate the observed phenotypes. Tbx15 and Tbx18
are both transcriptional repressors; however there are no known
targets of Tbx15, and ANF and Dll1 are the only known targets of
Tbx18 (Farin et al., 2007). Although Tbx18 is thought to directly
repress Dll1 expression in the rostral region of each somite, thereby
limiting its expression to the caudal portion, the loss of Tbx18 does
not result in the expansion of Dll1 expression (Bussen et al., 2004).
Instead, ectopic expression of Tbx18 in the somites leads to the
eventual reduction in Dll1 expression in the caudal somitic compart-
ment. We did not observe a detectable expansion of Dll1 expression in
our Tbx6 3-component embryos.
Bussen et al. (2004) showed that Tbx18 is not responsible for the
initial R–C patterning of the somites; instead, it appears to be required
for maintenance of R–C patterning. To this end, loss of Tbx18 results in
the eventual expansion of the uncx4.1 expression domain (a caudal
somite marker) into the rostral region, and the subsequent fusion of
pedicle regions of the vertebrae, which is indicative of a loss of rostral
sclerotome identity. This expansion is subtle and the authors suggest
that it is due to caudal somitic cells uncx4.1migrating into the rostral
region. In our experiments, ectopic myc-Tbx6 also results in the
expansion and fusion of pedicles, but we did not observe a detectable
expansion of uncx4.1 transcripts into the rostral region of the somite.
Instead, we observed an up-regulation of uncx4.1 expression in the
caudal halves of the somites. It is conceivable that this may lead to the
eventual expansion and fusion of the pedicles. The mosaic expression
of myc-Tbx6 in the 3-component embryos may contribute to
differences in phenotypes or intensity of phenotypes when compared
to the Tbx18 null embryo. Although marker gene expression patterns
were not strikingly different in our 3-component embryos compared
to controls, the phenotypic consequences of misexpression were
apparent. Due to the similarity of phenotypes observed in the Tbx15
and Tbx18 null embryos with that of our 3-component embryos, we
proposed that a competition between the ectopically expressed myc-
Tbx6 and endogenous Tbx15 and Tbx18 existed.
Tbx15 and Tbx18 are co-expressed within the proximal portion of
the limb bud mesenchyme (Bussen et al., 2004; Singh et al., 2005).
Several T-box factors are also expressed in the limb buds, including
Tbx2, Tbx3, Tbx4 (hindlimb only), Tbx5 (forelimb only), Tbx15, and
Tbx18. Tbx2 and Tbx3 are expressed within a strip of cells at the
anterior and posterior margins of the limb bud and are involved in
posterior digit identity (Davenport et al., 2003; Suzuki et al., 2004).
The limbs of Tbx18 null embryos are phenotypically normal, which
could stem from functional redundancy with other T-box factors
expressed within this domain. Ectopic Tbx6 expression in our 3-
component embryos results in limb phenotypes that are similar to a
loss of Tbx15, namely changes in the size and shape of the limb bones
and a hole in the scapula blade. Aside from Tbx15 functioning as a
transcriptional repressor, direct targets of Tbx15 are currently
unknown. The hole or foramen in the scapula is common to both
null mutations in Tbx15 and conditional removal of Tbx5 after the
initiation of limb bud outgrowth (Hasson et al., 2007). Fgf10 is a direct
target of Tbx5 in limb bud mesenchyme, and functions to maintain
Fgf8 expression in the AER in a feedback loop (Agarwal et al., 2003).We observed normal expression of Fgf8, indicating that Tbx5 function
is not likely to be affected, however we cannot exclude the possibility
that ectopic Tbx6 affects binding of Tbx5 to other downstream targets
or Tbx5 transcriptional activity at a level that cannot be observed by in
situ hybridization.
Competition between T-box transcription factors for binding to
endogenous targets within overlapping expression domains is not a
novel concept. During mouse heart development, Tbx2, a transcrip-
tional repressor, competes with Tbx5, a transcriptional activator for
binding to the ANF promoter within the atrio-ventricular canal and
outﬂow tract (Habets et al., 2002). We propose a similar competitive
mechanism in our 3-component embryos, where ectopic expression
of Tbx6 within the limb buds and somites interferes with the
transcriptional repressors Tbx15 and Tbx18 through a competition
for binding sites in the enhancers of downstream targets. Competition
between Tbx6 and Tbx18 for binding to the T-box binding sites within
the Dll1 enhancer has been previously proposed (Farin et al., 2007).
Herein we provide in vivo support of such competition.
Our luciferase assays suggest that Tbx6 and Tbx18 directly
compete at the Dll1-msd promoter. This could indeed reﬂect the in
vivo situation observed in our 3-component embryos. Tbx6 is required
in the PSM to activate Dll1 expression (White and Chapman, 2005),
and Tbx18 directly represses Dll1 within the rostral portion of each
somite, restricting its expression to the caudal half (Bussen et al.,
2004). Similar behavior was observed between Tbx6 and Tbx15 at the
Dll1-msd enhancer in our luciferase assays, suggesting a common
mechanism for competing at enhancer regions. We propose that this
competition occurs via direct binding of Tbx6 to the enhancer regions
of Tbx15/Tbx18 downstream targets, thus precluding Tbx15/Tbx18
binding. This competition is not exclusive to the Dll1 enhancer, as we
also noted that competition could occur at the ANF enhancer in
luciferase assays. Farin et al. (2007) hypothesized that Tbx18 may
compete with Tbx5 at the ANF promoter in the heart to inhibit
expression within the sinus horn mesenchyme. Tbx6 only weakly
activates transcription from the ANF promoter, however ANF is not an
endogenous Tbx6 target. Nevertheless, Tbx6-mediated activation
decreased in a linear fashion with the addition of Tbx18. Addition of
Tbx15 did not decrease Tbx6 activation. The simplest explanation for
differential competition is that considerably less myc-Tbx15 is
produced compared to myc-Tbx6 when equivalent amounts of
plasmid were transfected (Fig. 5a). These differences in expression
level could contribute to their ability to compete with Tbx6 in our
luciferase transcriptional assays.
Another explanation for the differential competition of Tbx15 and
Tbx18 is inefﬁcient binding of Tbx15 to the ANF promoter.
Comparisons of the DNA binding domains revealed that Tbx6 is 55%
identical to both Tbx15 and Tbx18 and ~69% similar within the DNA
binding domain; whereas Tbx15 and Tbx18 are 90% identical and 95%
similar. Based on the crystal structure of T and Tbx3 (Coll et al., 2002;
Muller and Herrmann, 1997), all residues presumably involved with
contacting DNA are conserved in Tbx6, Tbx15 and Tbx18. PCR-based
binding site selection assays demonstrated that both Tbx15 and Tbx18
bind to the canonical 5′-AGGTGT-3′ sequences and prefer a GA
dinucleotide 3′ of the half-site (Farin et al., 2007). Tbx6 has previously
been shown to bind to BS1 and BS2 within the Dll1-msd enhancer
(White and Chapman, 2005). Likewise, Tbx15 and Tbx18 can each
bind to BS1, while only Tbx18 binds to BS2. This difference in binding
preference could explain the differential competition of Tbx15 and
Tbx18 in our luciferase assays. Differences in binding site selection
between Tbx18 and Tbx15 may lie in preferences for orientation of
multiple half-sites. Tbx18 exclusively preferred a palindromic binding
sequence, while Tbx15 equally selected palindromic sequences and
direct repeats of the core sequence (Farin et al., 2007). This may result
in differential ability to compete with Tbx6 at each of the enhancers
tested. Although the afﬁnities of Tbx15 and Tbx18 for various binding
sites have not yet been determined, it is important to note that these
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reﬂect in vivo situations where co-factors can inﬂuence binding
afﬁnities.
Another possibility for differential competition that is notmutually
exclusive is that Tbx18 could simply serve as a stronger transcrip-
tional repressor than Tbx15. This is consistent with previous
observations whereby Tbx18 fused to the Gal4 DNA binding domain
repressed transcription from a Gal4-UAS synthetic enhancer more
effectively than Tbx15 (Farin et al., 2007). Both Tbx18 and Tbx15
interact with the Groucho co-repressor via a conserved eh1 domain
within the N-terminus of the protein to serve as transcriptional
repressors (Farin et al., 2007). Despite interacting with the same co-
repressor, Tbx18 still competes more efﬁciently than Tbx15 in our
luciferase assays at both tested enhancers.
In the absence of additional targets for these transcription factors
and antibodies suitable for chromatin immunoprecipitation, we can
only speculate at the mechanism underlying the phenotypes
generated by ectopic Tbx6 expression. Based on these phenotypes
and our luciferase assay results, we suggest that competition for
binding to endogenous enhancers occurs between the ectopically
expressed Tbx6 and endogenously expressed Tbx15 and Tbx18within
somitic tissue and the limb bud mesenchyme. The DNA binding
domain of Tbx18 and Tbx15 are also able to compete with Tbx6 to
effectively lower its activity, further suggesting that the observed
competition occurs at the level of DNA binding. Alternatively, ectopic
expression of Tbx6may compete for a common co-factor of Tbx15 and
Tbx18 that binds within the DNA binding domain. Previous studies
have suggested that Tbx15 and Tbx18 may interact with the paired
box transcription factor, Pax3 via the DNA binding domain (Farin
et al., 2008). It is not known whether Tbx6 can interact with Pax3. Yet
anothermechanism that could account for the observed phenotypes is
if Tbx6 physically interacted with Tbx15 and Tbx18 such that the
complex would prevent Tbx15/Tbx18 from acting as transcriptional
repressors. Co-immunoprecipitation experiments from cells co-
transfected with protein expression plasmids did not uncover
interactions between Tbx6 and Tbx15 or Tbx18 (Wehn and Chapman,
unpublished), however we cannot rule out interactions that may
occur in vivo.
In tissues where multiple T-box factors are normally co-expressed,
competition likely represents a mechanism that controls proper
transcription of target genes. This competition would be held in check
when all factors are expressed at their proper levels; however in
situations whereby the relative levels of T-box transcription factors
are altered would result in inappropriate target gene expression.
Haploinsufﬁciency for human TBX1, TBX3, TBX4, TBX5, and TBX22
result in the syndromes DiGeorge, ulna-mammary, Small Patella,
Holt–Oram, and X-linked cleft palate with ankyloglossia, respectively
(Baldini, 2003; Bamshad et al., 1997; Basson et al., 1997; Bongers et al.,
2004; Braybrook et al., 2001). Developmental processes are therefore
exquisitely sensitive to the levels of T-box transcription factors.
Accordingly, reducing the effective amount of any particular T-box
factor could allow for competition between resident T-box factors and
this competition could contribute to the observed phenotypes. This
highlights the importance of maintaining not only proper expression
domains, but also the appropriate levels of T-box transcription factors
during development.
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